Chapter VI – The state of the art at the search stage
2. State of the art – oral disclosure, etc.
According to Rule 33.1(a), relevant prior art consists of everything which has been made available to the public anywhere in the world by any means, thus including and Rule 33.1(b), oral disclosure, use, exhibition and other non-written disclosures, etc. are recognised as prior art. only when this is substantiated by a written disclosure, contrary to Art. 54 EPC.
See also ISPE Guidelines 11.22 and 15.05.
Where a non-written disclosure occurs and both the non-written disclosure and the a written account of it are publishedpublicly available before the relevant date as defined in Rule 64.1(b), the examiner will cite the written account in the search report and give the date of the written disclosure on the search report. In this case, the written disclosure constitutes the prior art.
If the written disclosure was made available to the public on or after the filing date of the international application concerned but, the written disclosure will be cited in the international search report together with the date on which it was available, provided that the non-written disclosure was made available to the public prior to the filingthat date of the international application, the non-written disclosure constitutes the prior art and should be mentioned by indicating its kind and the date on which it occurred in public. The written disclosure will also be cited in the international search report along with the date on which it was made available to the public. . The written opinion and the international preliminary examination report will draw attention to the non-written disclosure in Box No. VI (Certain documents cited).
Where a non-written disclosure occurs but is not followed by any written account, it is not cited in the international search report, because it is not considered to be state of the art under the PCT. The examiner makes a note of this non-written disclosure and will reconsider its status if the application enters the European phase before the EPO (see EPC Guidelines B‑VI, 2).